The cost of lung cancer in Alberta
作者： Sandor J Demeter , Philip Jacobs , Chester Chmielowiec , Wayne Logus , David Hailey
DOI: 10.1155/2007/847604
关键词: Intensive care medicine 、 Cancer 、 Medicine 、 Health economics 、 Economic impact analysis 、 Lung cancer
摘要: BACKGROUND: Lung cancer is the leading cause of morbidity and mortality. In addition, lung has a significant economic impact on society.
hindawi.com
core.ac.uk参考文章(16)
Mark A Rosenthal, Penny J Webster, Robin C Stuart‐Harris, Allan O Langlands, John Boyages, Val J Gebski, The cost of treating small cell lung cancer. The Medical Journal of Australia. ,vol. 156, pp. 605- 610 ,(1992) , 10.5694/J.1326-5377.1992.TB121456.X
Evans Wk, Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module. Seminars in Oncology. ,vol. 24, ,(1997)
L Jaakkimainen, P J Goodwin, J Pater, P Warde, N Murray, E Rapp, Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer. Journal of Clinical Oncology. ,vol. 8, pp. 1301- 1309 ,(1990) , 10.1200/JCO.1990.8.8.1301
B P Will, J M Berthelot, W K Evans, M C Wolfson, Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model. The Canadian journal of oncology. ,vol. 5, pp. 408- 419 ,(1995)
C C Earle, W K Evans, Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-cell lung cancer British Journal of Cancer. ,vol. 80, pp. 815- 820 ,(1999) , 10.1038/SJ.BJC.6690426
Konrad Fassbender, Robin Fainsinger, Carleen Brenneis, Pam Brown, Ted Braun, Philip Jacobs, Utilization and costs of the introduction of system-wide palliative care in Alberta, 1993/2000 Palliative Medicine. ,vol. 19, pp. 513- 520 ,(2005) , 10.1191/0269216305PM1071OA
D. Y. Lin, E. J. Feuer, R. Etzioni, Y. Wax, Estimating medical costs from incomplete follow-up data. Biometrics. ,vol. 53, pp. 419- 434 ,(1997) , 10.2307/2533947
Peter Coy, Joseph Schaafsma, John A Schofield, The cost-effectiveness and cost-utility of high-dose palliative radiotherapy for advanced non-small-cell lung cancer. International Journal of Radiation Oncology Biology Physics. ,vol. 48, pp. 1025- 1033 ,(2000) , 10.1016/S0360-3016(00)00713-6
Nestor F Esnaola, Sophia N Lazarides, Steven J Mentzer, Karen M Kuntz, Outcomes and Cost-Effectiveness of Alternative Staging Strategies for Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 20, pp. 263- 273 ,(2002) , 10.1200/JCO.20.1.263
Clifton F. Mountain, Revisions in the International System for Staging Lung Cancer Chest. ,vol. 111, pp. 1710- 1717 ,(1997) , 10.1378/CHEST.111.6.1710